Sexual dysfunction in women with cancer

Fertility and Sterility

Volumn 100, Issue 4, 2013, Pages 916-921

  Falk, Sandy J ^a,b   Dizon, Don S ^b,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTHRACYCLINE; AROMATASE INHIBITOR; CYCLOSPORIN; ESTRADIOL; ESTROGEN; LUBRICATING AGENT; TAMOXIFEN;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BODY IMAGE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVOR; COITUS; CONDOM; CONSULTATION; DYSPAREUNIA; ELASTICITY; ESTROGEN THERAPY; FEMALE SEXUAL DYSFUNCTION; GRAFT VERSUS HOST REACTION; GYNECOLOGIC CANCER; HUMAN; HUMIDIFIER; LUBRICATION; MARITAL THERAPY; MENOPAUSE; MULTIMODALITY CANCER THERAPY; OVARY INSUFFICIENCY; PATIENT CARE; PATIENT COUNSELING; PELVIC EXAMINATION; POPULATION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SELF CONCEPT; SEX THERAPY; SEXUAL AROUSAL; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SEXUAL HEALTH; SEXUAL PRACTICE; SEXUALITY; VAGINA ATROPHY; VAGINA DISCHARGE; VAGINAL DILATOR; VAGINISM; VULVODYNIA;

ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; NEOPLASMS; PROGNOSIS; RADIOTHERAPY; REPRODUCTIVE HEALTH; RISK FACTORS; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 84884902029     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2013.08.018     Document Type: Review

References (45)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders 5th ed. 2013 American Psychiatric Association Washington, DC
3. V.M. Barnabei, B.B. Cochrane, A.K. Aragaki, I. Nygaard, R.S. Williams, and P.G. McGovern Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative Obstet Gynecol 105 2005 1063 1073 (Pubitemid 40571027)
4. M.L. Krychman, J. Carter, C.A. Aghajanian, D.S. Dizon, and M. Castiel Chemotherapy-induced dyspareunia: a case study of vaginal mucositis and pegylated liposomal doxorubicin injection in advanced stage ovarian carcinoma Gynecol Oncol 93 2004 561 563 (Pubitemid 38507638)
5. T.M. De Pas, M. Mandalà, G. Curigliano, and F. Peccatori Acute vulvar vestibulitis occurring during chemotherapy with cryptophycin analogue LY355703 Obstet Gynecol 95 2000 1030 (Pubitemid 30251951)
6. A. Begovic-Juhant, A. Chmielewski, S. Iwuagwu, and L.A. Chapman Impact of body image on depression and quality of life among women with breast cancer J Psychosoc Oncol 30 2012 446 460
7. K. Bergmark, E. Avall-Lundqvist, P.W. Dickman, L. Henningsohn, and G. Steineck Vaginal changes and sexuality in women with a history of cervical cancer N Engl J Med 340 1999 1383 1389 (Pubitemid 29205401)
8. D.L. Wiggins, R. Wood, C.O. Granai, and D.S. Dizon Sex, intimacy, and the gynecologic oncologists: survey results of the New England Association of Gynecologic Oncologists (NEAGO) J Psychosoc Oncol 25 2007 61 70 (Pubitemid 350166023)
9. I.D. White, H. Allan, and S. Faithfull Assessment of treatment-induced female sexual morbidity in oncology: is this a part of routine medical follow-up after radical pelvic radiotherapy? Br J Cancer 105 2011 903 910
10. E.K. Hill, S. Sandbo, E. Abramsohn, J. Makelarski, K. Wroblewski, and E.R. Wenrich Assessing gynecologic and breast cancer survivors' sexual health care needs Cancer 117 2011 2643 2651
11. U. Boehmer, J. Potter, and D.J. Bowen Sexual functioning after cancer in sexual minority women Cancer J 15 2009 65 69
12. L. Aerts, P. Enzlin, I. Vergote, J. Verhaeghe, W. Poppe, and F. Amant Sexual, psychological, and relational functioning in women after surgical treatment for vulvar malignancy: a literature review J Sex Med 9 2012 361 371
13. V. Pumo, G. Milone, M. Iacono, S.R. Giuliano, A. Di Mari, and C. Lopiano Psychological and sexual disorders in long-term breast cancer survivors Cancer Manag Res 4 2012 61 65
14. R. Basson, and W.W. Schultz Sexual sequelae of general medical disorders Lancet 369 2007 409 424 (Pubitemid 46177229)
15. R. Basson Clinical practice: sexual desire and arousal disorders in women N Engl J Med 354 2006 1497 1506
16. M.L. Krychman, and A. Katz Breast cancer and sexuality: multi-modal treatment options J Sex Med 9 2012 5 13
17. W.F. Griffith, G.S. Stuart, K.L. Gluck, and S.F. Heartwell Vaginal speculum lubrication and its effects on cervical cytology and microbiology Contraception 72 2005 60 64 (Pubitemid 40827120)
18. J.K. Hathaway, P.K. Pathak, and R. Maney Is liquid-based Pap testing affected by water-based lubricant? Obstet Gynecol 107 2006 66 70
19. R. Siegel, C. DeSantis, K. Virgo, K. Stein, A. Mariotto, and T. Smith Cancer treatment and survivorship statistics, 2012 CA Cancer J Clin 62 2012 220 241
20. T. Dorjgochoo, K. Gu, A. Kallianpur, Y. Zheng, W. Zheng, and Z. Chen Menopausal symptoms among breast cancer patients 6 months after diagnosis: a report from the Shanghai Breast Cancer Survival Study Menopause 16 2009 1205 1212
21. J. Baumgart, K. Nilsson, A.S. Evers, T.K. Kallak, and I.S. Poromaa Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer Menopause 20 2013 162 168
22. D. Herbenick, M. Reece, D. Hensel, S. Sanders, K. Jozkowski, and J.D. Fortenberry Association of lubricant use with women's sexual pleasure, sexual satisfaction, and genital symptoms: a prospective daily diary study J Sex Med 8 2011 202 212
23. M. Bygdeman, and M.L. Swahn Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women Maturitas 23 1996 259 263 (Pubitemid 26000605)
24. L.E. Nachtigall Comparative study: Replens versus local estrogen in menopausal women Fertil Steril 61 1994 178 180 (Pubitemid 24030700)
25. L. Cardozo, G. Bachmann, D. McClish, D. Fonda, and L. Birgerson Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee Obstet Gynecol 92 1998 722 727 (Pubitemid 28440818)
26. C.Y. Long, C.M. Liu, S.C. Hsu, C.H. Wu, C.L. Wang, and E.M. Tsai A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal women Menopause 13 2006 737 743
27. M. Notelovitz, S. Funk, N. Nanavati, and M. Mazzeo Estradiol absorption from vaginal tablets in postmenopausal women Obstet Gynecol 99 2002 556 562 (Pubitemid 34246288)
28. E. Weisberg, R. Ayton, G. Darling, E. Farrell, A. Murkies, and S. O'Neill Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet Climacteric 8 2005 83 92 (Pubitemid 40675125)
29. R.R. Barakat, B.N. Bundy, N.M. Spirtos, J. Bell, and R.S. Mannel Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study J Clin Oncol 24 2006 587 592 (Pubitemid 46630420)
30. V. de Giorgi, A. Gori, S. Gandini, F. Papi, M. Grazzini, and S. Rossari Oestrogen receptor beta and melanoma: a comparative study Br J Dermatol 168 2013 513 519
31. K.A. Suriano, M. McHale, C.E. McLaren, K.T. Li, A. Re, and P.J. DiSaia Estrogen replacement therapy in endometrial cancer patients: a matched control study Obstet Gynecol 97 2001 555 560
32. J.E. Dew, B.G. Wren, and J.A. Eden A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer Climacteric 6 2003 45 52 (Pubitemid 36398872)
33. A. Kendall, M. Dowsett, E. Folkerd, and I. Smith Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors Ann Oncol 17 2006 584 587
34. G. Pfeiler, C. Glatz, R. Königsberg, T. Geisendorfer, A. Fink-Retter, and E. Kubista Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients Climacteric 14 2011 339 344
35. Serum estradiol levels in postmenopausal women with breast cancer receiving adjuvant aromatase inhibitors and vaginal estrogen. ClinicalTrials.gov, http://clinicaltrials.gov/show/NCT00984399.
36. North American Menopause Society The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of the North American Menopause Society Menopause 14 2007 355 369
37. R.H. Straub The complex role of estrogens in inflammation Endocr Rev 28 2007 521 574 (Pubitemid 47236336)
38. A.Y. Bahng, A. Dagan, D.W. Bruner, and L.L. Lin Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer Int J Radiat Oncol Biol Phys 82 2012 667 673
39. G.H. Eltabbakh, M.S. Piver, R.E. Hempling, and K.H. Shin Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial Int J Radiat Oncol Biol Phys 38 1997 373 380 (Pubitemid 27318655)
40. P. Hartman, and A.W. Diddle Vaginal stenosis following irradiation therapy for carcinoma of the cervix uteri Cancer 30 1972 426 429
41. I.B. Fraunholz, B. Schopohl, S. Falk, and H.D. Boettcher Cytohormonal status and acute radiation vaginitis Front Radiat Ther Oncol 37 2002 112 120
42. S.J. Lee, G. Vogelsang, A. Gilman, D.J. Weisdorf, S. Pavletic, and J.H. Antin A survey of diagnosis, management, and grading of chronic GVHD Biol Blood Marrow Transplant 8 2002 32 39 (Pubitemid 34141549)
43. C. Riera, Y. Deroover, and M. Marechal Severe vaginal chronic graft-versus-host disease (GVHD): two cases with late onset and literature review Eur J Gynaecol Oncol 31 2010 703 704
44. L.B. Spiryda, M.R. Laufer, R.J. Soiffer, and J.A. Antin Graft-versus-host disease of the vulva and/or vagina: diagnosis and treatment. Biol Blood Marrow Transplant 9 2003 760 765 (Pubitemid 38145745)
45. H.E. Lotery, and R.P. Galask Erosive lichen planus of the vulva and vagina Obstet Gynecol 101 2003 1121 1125